317 related articles for article (PubMed ID: 35175369)
1. [The role of the microbiome in diseases of the pancreas].
Frost F; Weiss FU; Lerch MM
Internist (Berl); 2022 Apr; 63(4):372-378. PubMed ID: 35175369
[TBL] [Abstract][Full Text] [Related]
2. The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens.
Frost F; Weiss FU; Sendler M; Kacprowski T; Rühlemann M; Bang C; Franke A; Völker U; Völzke H; Lamprecht G; Mayerle J; Aghdassi AA; Homuth G; Lerch MM
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00232. PubMed ID: 33094959
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity].
Maev IV; Levchenko AI; Galeeva JS; Andreev DN; Osipenko JV; Bordin DS; Ilyina EN
Ter Arkh; 2023 Mar; 95(2):130-139. PubMed ID: 37167128
[TBL] [Abstract][Full Text] [Related]
4. [Introduction to the microbiome].
Frost F
Inn Med (Heidelb); 2022 Oct; 63(10):1015-1021. PubMed ID: 36053301
[TBL] [Abstract][Full Text] [Related]
5. The Interaction of Microbiome and Pancreas in Acute Pancreatitis.
Zhang C; Li G; Lu T; Liu L; Sui Y; Bai R; Li L; Sun B
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254659
[TBL] [Abstract][Full Text] [Related]
6. Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
Frost F; Kacprowski T; Rühlemann M; Pietzner M; Bang C; Franke A; Nauck M; Völker U; Völzke H; Dörr M; Baumbach J; Sendler M; Schulz C; Mayerle J; Weiss FU; Homuth G; Lerch MM
Gut; 2021 Mar; 70(3):522-530. PubMed ID: 33168600
[TBL] [Abstract][Full Text] [Related]
7. Pancreas-Microbiota Cross Talk in Health and Disease.
Adolph TE; Mayr L; Grabherr F; Schwärzler J; Tilg H
Annu Rev Nutr; 2019 Aug; 39():249-266. PubMed ID: 31433743
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.
Zhu Y; He C; Li X; Cai Y; Hu J; Liao Y; Zhao J; Xia L; He W; Liu L; Luo C; Shu X; Cai Q; Chen Y; Lu N
J Gastroenterol; 2019 Apr; 54(4):347-358. PubMed ID: 30519748
[TBL] [Abstract][Full Text] [Related]
9. Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients.
Sammallahti H; Kokkola A; Rezasoltani S; Ghanbari R; Asadzadeh Aghdaei H; Knuutila S; Puolakkainen P; Sarhadi VK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884776
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome in Pancreatic Disease.
Akshintala VS; Talukdar R; Singh VK; Goggins M
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):290-295. PubMed ID: 30144522
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in acute pancreatitis: A review based on current literature.
Patel BK; Patel KH; Bhatia M; Iyer SG; Madhavan K; Moochhala SM
World J Gastroenterol; 2021 Aug; 27(30):5019-5036. PubMed ID: 34497432
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
13. Impacts of pancreatic exocrine insufficiency on gut microbiota.
Guo Y; Cao F; Li F
J Zhejiang Univ Sci B; 2024 Apr; 25(4):271-279. PubMed ID: 38584090
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
[TBL] [Abstract][Full Text] [Related]
15. Microbiota in pancreatic health and disease: the next frontier in microbiome research.
Thomas RM; Jobin C
Nat Rev Gastroenterol Hepatol; 2020 Jan; 17(1):53-64. PubMed ID: 31811279
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders.
Pagliari D; Saviano A; Newton EE; Serricchio ML; Dal Lago AA; Gasbarrini A; Cianci R
Mediators Inflamm; 2018; 2018():7946431. PubMed ID: 29563853
[TBL] [Abstract][Full Text] [Related]
17. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
[TBL] [Abstract][Full Text] [Related]
18. The role of gut microbiota in the pathogenesis and treatment of acute pancreatitis: a narrative review.
Lu WW; Chen X; Ni JL; Zhu SL; Fei AH; Wang XS
Ann Palliat Med; 2021 Mar; 10(3):3445-3451. PubMed ID: 33849128
[TBL] [Abstract][Full Text] [Related]
19. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice.
Li X; He C; Li N; Ding L; Chen H; Wan J; Yang X; Xia L; He W; Xiong H; Shu X; Zhu Y; Lu N
Gut Microbes; 2020 Nov; 11(6):1774-1789. PubMed ID: 32529941
[TBL] [Abstract][Full Text] [Related]
20. Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics.
Yang Q; Zhang J; Zhu Y
Front Cell Infect Microbiol; 2022; 12():872019. PubMed ID: 35463649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
